Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on: February 23,2024

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on:February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on: January 30,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on:January 30,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on: May 06,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on:May 06,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on: April 20,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on:April 20,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on: April 10,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on:April 10,2024

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on: February 23,2024

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on:February 23,2024

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It

Updated on: January 30,2024

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It

Updated on:January 30,2024